Dr. Jing Xue
Woodland Hills, Los Angeles, CA ? 518-***-**** ? acdzj6@r.postjobfree.com
Research Scientist
Biochemistry ~ Structural Biology ~ Pharmaceuticals ~ Quality
Assurance/Control
Profile
. HIGHLY SKILLED AT PROTEIN PURIFICATION UTILIZING AFFINITY
CHROMATOGRAPHY, ION EXCHANGE CHROMATOGRAPHY AND HIGH PERFORMANCE
LIQUID CHROMATOGRAPHY (HPLC).
. Adept at biochemical protein imaging and testing via SDS-PAGE
(Polyacrylamide Gel Electrophoresis), native PAGE, Western Blot,
Enzyme-linked Immunosorbent Assays (ELISA) and fluorescent titrations
at low protein concentrations.
. Considerable skills in native chemical ligation by using intein-based
chemistry.
. Experienced with homonuclear and heteronuclear triple resonance NMR
(Nuclear Magnetic Resonance) experiments and chemical shifts
assignments and structure determination.
. Mass spectrometry (MS) (ESI/MS and MS/MS) based chemical cross-linking
for the spatial determination of protein 3D conformations.
. Well-versed in Good Laboratory Practices (GLP) and safety rules and
regulations including WHMIS and HACCP.
. Proven talents in plasmid construction, site-directed mutagenesis, PCR
and Agarose Gel Electrophoresis, protein expression in E.coli
biological system, and animal cell culture.
. Meticulously document procedures, calculations, measurements,
observations, and analysis of results.
. Proficient at calibrating and using wide range of laboratory
equipment, performing cell culture, isolating DNA, preparing
solutions, assay development, and designing experiments.
. Able to perform laser scanning confocal microscopy and fluorescent
microscopy to monitor mobility of dual-labeled actin.
Education
PHD, BIOCHEMISTRY, UNIVERSITY AT ALBANY-STATE UNIVERSITY OF NEW YORK, 2013
Dissertation: "Structural Biology of the Receptor for Advanced Glycation
End-products (RAGE)"
Bachelor of Science, Pharmaceutics, Nanjing University of Chinese Medicine,
2008
Scholarship Recipient, Nanjing University of Chinese Medicine, 2005 to 2007
Excellent League Leadership Recognition, 2007
Chief Editor, Magazines in College of Pharmaceutics in 2006 to 2007
Professional Experience
UNIVERSITY AT ALBANY- STATE UNIVERSITY OF NEW YORK, RESEARCH FOUNDATION,
2013 TO PRESENT
Post-doctoral Researcher
. Actively support Associate Professor in broad-scope research projects
including experiment design and paper writing.
. Apply dynamic leadership talents toward guiding and mentoring
graduate/undergraduate students throughout all phases of research
projects.
. Explore and characterize functional protein structures in eukaryotic
cells by using elelctroporation.
. Proficiently use STINT-NMR method for studying in-cell protein-protein
interactions.
Continued ...
Dr. Jing Xue - Page 2 of 2
Professional Experience continued ...
University at Albany- State University of New York, 2008 to 2013
PhD Student
. Studied solution structure of RAGE bound to its physiological ligand
S100B and documented findings.
. Elucidated signal transduction mechanism of S100B binding to weakly
oligomerized RAGE via both high
resolution NMR spectroscopy and Mass Spectrometry (MS) based chemical
cross-linking.
. Successfully revealed recognition of Advanced Glycation End-products
(AGEs), particularly N?-carboxymethyal(ethyl)-lysine and methylglyoxal-
derived hydroimidazolones (MG-H) by RAGE V domain.
. Combined sequentially expressed two or more proteins within single
bacterial or mammalian cell and monitored their interactions by using
STINT-NMR technique.
. Performed NMR spectroscopy to characterize bioavailability of small
molecules in mouse plasma.
. Used expressed protein ligation to study protein structure and
function of immunoglobulin-like receptor, RAGE, in vitro.
. Conducted transfection of mammalian cells (HEK293T) with isotopic
labeled proteins or recombinant DNA plasmids.
Publications
XUE J, SCALABRIN M, REVERDATTO S, FABRIS D, SHEKHTMAN A "STRUCTURAL BIOLOGY
OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE)" IN PREPARATION.
Xue J, Boehme D, Burz DS, Hoffman R, Shekhtman A "Specific Recognition of
Methylglyoxal Derived AGEs by the Receptor for Advanced Glycation End
Products (RAGE)" Accepted by ACS Biochemistry.
Reverdatto S, Rai V, Xue J, Burz DS, Schmidt AM, Shekhtman A "Combinatorial
Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal
Transduction in Mammalian Cells." PLoS One. 2013 Jun 13;8(6):e65180. doi:
10.1371/journal.pone.0065180. Print 2013.
Xue J, Burz DS, Shekhtman A "Segmental labeling to study multidomain
proteins." Adv Exp Med Biol. 2012;992:17-33. doi: 10.1007/978-**-***-****-
2_2. Review.
Xue J, Rai V, Singer D, Chabierski S, Xie J, Reverdatto S, Burz DS, Schmidt
AM, Hoffmann R, Shekhtman A "Advanced glycation end product recognition by
the receptor for AGEs." Structure. 2011 May 11;19(5):722-32. doi:
10.1016/j.str.2011.02.013. Reviewed in Volker D tsch, How to create a
specific recognition for an unspecific interaction, Structure 2011, 19:601-
602.
Paskaleva EE, Xue J, Lee DY, Shekhtman A, Canki M "Palmitic acid analogs
exhibit nanomolar binding affinity for the HIV-1 CD4 receptor and nanomolar
inhibition of gp120-to-CD4 fusion." PLoS One. 2010 Aug 13;5(8):e12168. doi:
10.1371/journal.pone.0012168.
Computer Skills
NMR SPECTROSCOPY AND STRUCTURAL BIOLOGY: CARA1.8.4.2, CYANA 2.1, DISCOVERY
STUDIO, HADDOCK
Mass Spectroscopy: Xcalibur
Bioinformatics: Vector NTI Advance, GraphPad Prism 5
Programming: Matlab R2012, OriginPro8
Graphic Design: Adobe Master Collection CS4
[pic][pic][pic][pic]